Curadel Pharma Initiates Phase 3 Trial of ZW800-1, a First-in-Class Zwitterionic Drug for Optical Surgical Navigation
Curadel Pharma has initiated a Phase 3 study on ZW800-1 (nizaracianine triflutate) to highlight the ureter during abdominopelvic surgery.
pharmaphorum8d
12 Questions with Alex Guillen
As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's ...
The Inner Circle acknowledges, Edward R Nasi as an Inner Circle Lifetime member
Prominently featured in The Inner Circle, Edward R Nasi is acknowledged as an Inner Circle Lifetime for his contributions to the Pharmaceutical Industry.
MedPage Today on MSN14d
Topical JAK Inhibitor Active in Itchy Prurigo Nodularis
ORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of ...
Briefly on MSN6d
Rashaun Williams' net worth: the investments that made him rich
Rashaun Williams is an American entrepreneur, venture capitalist, and philanthropist famous as a guest Shark on Shark Tank.
TwistedSifter on MSN8d
After Discovering His Ex-Uncle Cheated And Lied During The Divorce, This Law Student Took Action To Get Revenge For His Aunt
That is what happened to the young man in this story, so he plotted revenge that cost the man his new marriage, his money, ...
API maker Granules Pharma simplifies structure involving US subsidiaries
The exercise is aimed at reducing legal entities and simplify operating structure, said Granules Pharma, and the plan is expected to reduce the number of legal entities, simplify operational ...
Fierce Pharma7h
AstraZeneca, Pfizer rebuked over breaking UK drug marketing rules on LinkedIn use
The PMCPA has dug into the industry’s LinkedIn activities once again. | The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZeneca received the harshest censure in the latest ...
Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?
Recursion Pharmaceuticals ( RXRX -3.73%) has gained a lot of attention in recent years with an AI-powered drug-discovery platform that aims to reduce the amount of trial and error that's required to ...
Purdue Pharma Files New Bankruptcy Plan—Includes Up To $7 Billion From Sacklers
The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.
NFL signs Novartis as first pharmaceutical partner-source
The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...